A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines
NCT02108158
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
Azzalure
Sponsor
Galderma R&D